NCT02627118View on ClinicalTrials.gov

Potential Effect of Dialyzer Leaching of BPA From the Fresenius Optiflux 160NR Compared to the Nipro ELISIO-15H

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

July 11, 2016

Study Completion Date

July 11, 2016

Conditions
End Stage Renal Disease
Interventions
DEVICE

FRESENIUS 160NR

2 MONTHS OF DIALYSIS WITH THE FRESENIUS 160NR DIALYZER

DEVICE

NIPRO ELISIO-15H

2 MONTHS OF DIALYSIS WITH THE NIPRO ELISIO-15H DIALYZER

Sponsors

Collaborators (1)

Nipro Medical Corporation
All Listed Sponsors
collaborator

Nipro Medical Corporation

INDUSTRY

collaborator

Dialysis Clinic, Inc.

INDUSTRY

lead

UConn Health

OTHER

NCT02627118 - Potential Effect of Dialyzer Leaching of BPA From the Fresenius Optiflux 160NR Compared to the Nipro ELISIO-15H | Biotech Hunter | Biotech Hunter